Scientists map genetic drivers of kidney disease, opening path to new treatments

Researchers identified the molecular pathways that trigger IgA nephropathy, a leading cause of kidney failure worldwide, using genome-wide analysis. The findings pinpoint specific drug targets that could halt disease progression, potentially reducing dialysis demand and offering pharma companies new therapeutic opportunities in a disease affecting millions.

Originaltitel: Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy